Table 1.
Descriptive statistics of the study cohort (N = 384).
| Mean | SD | n | |
| Age | 61.75 | 8.05 | 384 |
| BMI | 25.76 | 3.98 | 384 |
| Psychological distress | 7.45 | 5.87 | 382 |
| Cognitive Reserve | 36.28 | 7.78 | 360 |
| Resilience | 78.45 | 12.72 | 382 |
| General Health | 73.92 | 19.74 | 328 |
| Time since chemotherapy |
72.56 |
14.36 |
252 |
| Median |
IQR |
n |
|
| Pain Intensity | 3 | 1–5 | 384 |
| Pain Interference | 1 | 0–4 | 384 |
| Insomnia symptoms |
6 |
3–11 |
379 |
| n |
% |
||
| Pain sites | |||
| 0 | 66 | 17 | |
| 1-2 | 178 | 46 | |
| 3 or more | 140 | 36 | |
| Education | |||
| Low | 53 | 14 | |
| Medium | 87 | 23 | |
| High | 244 | 64 | |
| Adjuvant treatments | |||
| Chemotherapy | 253 | 66 | |
| Radiotherapy | 260 | 68 | |
| Endocrine therapy | 285 | 75 | |
Age in years; BMI = Body Mass Index; Psychological distress (HADS, [0–42]); Cognitive Reserve (CRS, [0–80]); Resilience (RS-14, [14–98]); General Health (General Health subdimension in SF-36, [0–100]); Time since chemotherapy (months); Insomnia Symptoms (ISI, [0–28]); Pain Intensity NRS (0–10); Pain interference NRS (0–10); Interquartile range (IQR).